000028 国药一致
已收盘 11-19 15:00:00
资讯
新帖
简况
国药一致(000028)11月10日主力资金净卖出974.17万元
证券之星 · 11-11
国药一致(000028)11月10日主力资金净卖出974.17万元
国药一致(000028)11月5日主力资金净卖出66.38万元
证券之星 · 11-06
国药一致(000028)11月5日主力资金净卖出66.38万元
国药一致(000028)2026年三季报简析:净利润同比下降0.48%
证券之星 · 11-01
国药一致(000028)2026年三季报简析:净利润同比下降0.48%
图解国药一致三季报:第三季度单季净利润同比增长18.91%
证券之星 · 10-31
图解国药一致三季报:第三季度单季净利润同比增长18.91%
国药一致(000028.SZ)发布前三季度业绩,归母净利润9.52亿元,同比下降0.48%
智通财经 · 10-30
国药一致(000028.SZ)发布前三季度业绩,归母净利润9.52亿元,同比下降0.48%
国药一致(000028)10月22日主力资金净卖出323.72万元
证券之星 · 10-23
国药一致(000028)10月22日主力资金净卖出323.72万元
股市必读:国药一致新发布《2026年度前三季度业绩快报》
证券之星 · 10-22
股市必读:国药一致新发布《2026年度前三季度业绩快报》
国药一致(000028)披露2026年度前三季度业绩快报,10月20日股价下跌1.56%
证券之星 · 10-20
国药一致(000028)披露2026年度前三季度业绩快报,10月20日股价下跌1.56%
国药控股(01099):国药一致第三季度实现归母净利润3.46亿元 同比增长18.91%
智通财经 · 10-20
国药控股(01099):国药一致第三季度实现归母净利润3.46亿元 同比增长18.91%
国药一致(000028.SZ)前三季度归母净利润9.52亿元 同比下降0.48%
智通财经 · 10-20
国药一致(000028.SZ)前三季度归母净利润9.52亿元 同比下降0.48%
国药一致(000028)10月14日主力资金净卖出682.15万元
证券之星 · 10-15
国药一致(000028)10月14日主力资金净卖出682.15万元
国药一致(000028)10月12日主力资金净卖出16.93万元
证券之星 · 10-13
国药一致(000028)10月12日主力资金净卖出16.93万元
股市必读:国药一致(000028)9月24日董秘有最新回复
证券之星 · 09-28
股市必读:国药一致(000028)9月24日董秘有最新回复
股市必读:国药一致(000028)9月9日董秘有最新回复
证券之星 · 09-10
股市必读:国药一致(000028)9月9日董秘有最新回复
国药一致:该项目尚在施工中,未来会使用现代化技术设备
证券之星 · 09-09
国药一致:该项目尚在施工中,未来会使用现代化技术设备
股市必读:国药一致(000028)8月31日董秘有最新回复
证券之星 · 09-01
股市必读:国药一致(000028)8月31日董秘有最新回复
国药一致:主业优化与提质增效方面,公司持续推进组织结构优化,巩固传统分销基本盘、加快培育新增长引擎,并成立医疗器械中心、医学业务部等,强化专业化运营能力
证券之星 · 08-31
国药一致:主业优化与提质增效方面,公司持续推进组织结构优化,巩固传统分销基本盘、加快培育新增长引擎,并成立医疗器械中心、医学业务部等,强化专业化运营能力
国药一致:通过严格资信管控、专项跟踪清收、持续对账确权、强化法律催收等手段,最大限度降低坏账损失风险
证券之星 · 08-31
国药一致:通过严格资信管控、专项跟踪清收、持续对账确权、强化法律催收等手段,最大限度降低坏账损失风险
股市必读:国药一致中报 - 第二季度单季净利润同比下降5.67%
证券之星 · 08-31
股市必读:国药一致中报 - 第二季度单季净利润同比下降5.67%
每周股票复盘:国药一致(000028)2026上半年营收362.66亿
证券之星 · 08-30
每周股票复盘:国药一致(000028)2026上半年营收362.66亿
加载更多
公司概况
公司名称:
国药集团一致药业股份有限公司
所属行业:
批发业
上市日期:
1993-08-09
主营业务:
国药集团一致药业股份有限公司的主营业务是医药分销和医药零售。公司的主要产品是药品、器械耗材、诊断试剂、仪器设备。
发行价格:
3.50
{"stockData":{"symbol":"000028","market":"SZ","secType":"STK","nameCN":"国药一致","latestPrice":20.97,"timestamp":1795071834000,"preClose":21.24,"halted":0,"volume":2833634,"delay":0,"changeRate":-0.0127,"floatShares":526000000,"shares":612000000,"eps":1.8479,"marketStatus":"已收盘","change":-0.27,"latestTime":"11-19 15:00:00","open":21.16,"high":21.3,"low":20.92,"amount":59656200,"amplitude":0.0179,"askPrice":21.04,"askSize":2,"bidPrice":20.97,"bidSize":24,"shortable":0,"etf":0,"ttmEps":1.8479,"tradingStatus":0,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1795138200000},"marketStatusCode":5,"adr":0,"adjPreClose":21.24,"symbolType":"stock","openAndCloseTimeList":[[1795051800000,1795059000000],[1795064400000,1795071600000]],"highLimit":23.36,"lowLimit":19.12,"ibTradeSell":false,"ibTradeBuySell":true,"totalEquity":612221584,"isCdr":false,"pbRate":0.68,"roa":"--","peRate":11.348017,"roe":"5.03%","epsLYR":2.04,"committee":0.056962,"marketValue":12838000000,"turnoverRate":0.0054,"status":1,"floatMarketCap":11027000000},"requestUrl":"/m/hq/s/000028","defaultTab":"news","newsList":[{"id":"2682234453","title":"国药一致(000028)11月10日主力资金净卖出974.17万元","url":"https://stock-news.laohu8.com/highlight/detail?id=2682234453","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2682234453?lang=zh_cn&edition=full","pubTime":"2026-11-11 09:19","pubTimestamp":1794359948,"startTime":"0","endTime":"0","summary":"证券之星消息,截至2026年11月10日收盘,国药一致报收于21.09元,下跌1.08%,换手率0.52%,成交量2.75万手,成交额5822.87万元。融券方面,融券卖出2100.0股,融券偿还800.0股,融券余量11.09万股,融券余额233.95万元。国药一致主营业务:核心业务涵盖以两广区域为主体的医药分销业务和以国大药房为主体的全国性社会药房零售业务,此外还参股医药工业企业。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026111100014508.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0010","BK0175","000028","BK0196","BK0250","BK0188","BK0185","BK0028","BK0082"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2681882033","title":"国药一致(000028)11月5日主力资金净卖出66.38万元","url":"https://stock-news.laohu8.com/highlight/detail?id=2681882033","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2681882033?lang=zh_cn&edition=full","pubTime":"2026-11-06 09:18","pubTimestamp":1793927928,"startTime":"0","endTime":"0","summary":"证券之星消息,截至2026年11月5日收盘,国药一致报收于21.5元,下跌0.78%,换手率0.92%,成交量4.83万手,成交额1.03亿元。融券方面,融券卖出8000.0股,融券偿还600.0股,融券余量11.8万股,融券余额253.76万元。国药一致主营业务:核心业务涵盖以两广区域为主体的医药分销业务和以国大药房为主体的全国性社会药房零售业务,此外还参股医药工业企业。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026110600009606.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0082","BK0196","BK0250","000028","BK0188","BK0028","BK0185","BK0175","BK0010"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2680515272","title":"国药一致(000028)2026年三季报简析:净利润同比下降0.48%","url":"https://stock-news.laohu8.com/highlight/detail?id=2680515272","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2680515272?lang=zh_cn&edition=full","pubTime":"2026-11-01 06:32","pubTimestamp":1793485935,"startTime":"0","endTime":"0","summary":"据证券之星公开数据整理,近期国药一致发布2026年三季报。根据财报显示,国药一致净利润同比下降0.48%。截至本报告期末,公司营业总收入550.66亿元,同比下降0.11%,归母净利润9.52亿元,同比下降0.48%。按单季度数据看,第三季度营业总收入188.0亿元,同比上升2.57%,第三季度归母净利润3.46亿元,同比上升18.91%。去年的净利率为1.54%,算上全部成本后,公司产品或服务的附加值不高。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026110100001690.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["000028"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2679241038","title":"图解国药一致三季报:第三季度单季净利润同比增长18.91%","url":"https://stock-news.laohu8.com/highlight/detail?id=2679241038","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2679241038?lang=zh_cn&edition=full","pubTime":"2026-10-31 01:49","pubTimestamp":1793382580,"startTime":"0","endTime":"0","summary":"证券之星消息,国药一致2026年三季报显示,前三季度公司主营收入550.66亿元,同比下降0.11%;归母净利润9.52亿元,同比下降0.48%;扣非净利润9.45亿元,同比上升2.36%;其中2026年第三季度,公司单季度主营收入188.0亿元,同比上升2.57%;单季度归母净利润3.46亿元,同比上升18.91%;单季度扣非净利润3.46亿元,同比上升23.47%;负债率54.48%,投资收益1.26亿元,财务费用9776.99万元,毛利率10.11%。财报数据概要请见下图:本文数据来源于国药一致2026年三季报,仅供参考不构成投资建议。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026103100003727.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["000028"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2679329513","title":"国药一致(000028.SZ)发布前三季度业绩,归母净利润9.52亿元,同比下降0.48%","url":"https://stock-news.laohu8.com/highlight/detail?id=2679329513","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2679329513?lang=zh_cn&edition=full","pubTime":"2026-10-30 17:04","pubTimestamp":1793351071,"startTime":"0","endTime":"0","summary":"智通财经APP讯,国药一致(000028.SZ)发布2026年三季度报告,前三季度,公司实现营业收入550.66亿元,同比下降0.11%。归属于上市公司股东的净利润9.52亿元,同比下降0.48%。归属于上市公司股东的扣除非经常性损益的净利润9.45亿元,同比增长2.36%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1516128.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["000028"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2677915809","title":"国药一致(000028)10月22日主力资金净卖出323.72万元","url":"https://stock-news.laohu8.com/highlight/detail?id=2677915809","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2677915809?lang=zh_cn&edition=full","pubTime":"2026-10-23 09:07","pubTimestamp":1792717660,"startTime":"0","endTime":"0","summary":"证券之星消息,截至2026年10月22日收盘,国药一致报收于20.58元,上涨0.24%,换手率0.66%,成交量3.48万手,成交额7148.55万元。融券方面,融券卖出8100.0股,融券偿还5700.0股,融券余量12.02万股,融券余额247.45万元。国药一致主营业务:核心业务涵盖以两广区域为主体的医药分销业务和以国大药房为主体的全国性社会药房零售业务,此外还参股医药工业企业。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026102300009167.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0028","BK0196","BK0250","BK0188","BK0175","000028","BK0185","BK0010","BK0082"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2677606002","title":"股市必读:国药一致新发布《2026年度前三季度业绩快报》","url":"https://stock-news.laohu8.com/highlight/detail?id=2677606002","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2677606002?lang=zh_cn&edition=full","pubTime":"2026-10-22 02:02","pubTimestamp":1792605736,"startTime":"0","endTime":"0","summary":"截至2026年10月21日收盘,国药一致报收于20.53元,上涨1.99%,换手率1.03%,成交量5.43万手,成交额1.12亿元。当日关注点交易信息汇总:10月21日主力资金净流入518.07万元,占总成交额4.62%。公司公告汇总:国药一致发布2026年前三季度业绩快报,第三季度归母净利润3.46亿元,同比增长18.91%。分销板块收入405.65亿元,同比下降0.07%,净利润同比增长4.28%;零售板块收入152.34亿元,同比增长0.05%,净利润同比增长105.08%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026102200001427.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0010","BK0196","BK0028","BK0082","BK0250","BK0175","BK0185","000028","BK0188"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2676569236","title":"国药一致(000028)披露2026年度前三季度业绩快报,10月20日股价下跌1.56%","url":"https://stock-news.laohu8.com/highlight/detail?id=2676569236","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2676569236?lang=zh_cn&edition=full","pubTime":"2026-10-20 22:47","pubTimestamp":1792507634,"startTime":"0","endTime":"0","summary":"截至2026年10月20日收盘,国药一致报收于20.13元,较前一交易日下跌1.56%,最新总市值为123.24亿元。该股当日开盘20.37元,最高20.47元,最低19.96元,成交额达5165.6万元,换手率为0.49%。公告显示,公司营业总收入550.66亿元,同比下降0.11%;归属于上市公司股东的净利润9.52亿元,同比下降0.48%。第三季度营业收入188.00亿元,同比增长2.57%;归母净利润3.46亿元,同比增长18.91%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026102000037378.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0010","BK0196","BK0082","BK0250","BK0175","000028","BK0185","BK0188","BK0028"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2676454699","title":"国药控股(01099):国药一致第三季度实现归母净利润3.46亿元 同比增长18.91%","url":"https://stock-news.laohu8.com/highlight/detail?id=2676454699","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2676454699?lang=zh_cn&edition=full","pubTime":"2026-10-20 21:35","pubTimestamp":1792503325,"startTime":"0","endTime":"0","summary":"智通财经APP讯,国药控股(01099)公布,国药一致2026年前三季度实现营业总收入约550.66亿元,同比减少0.11%;归属于上市公司股东的净利润约9.52亿元,同比减少0.48%;基本每股收益1.56元。2026年第三季度,实现营业收入188.00亿元,同比增长2.57%;归属上市公司股东的净利润3.46亿元,同比增长18.91%。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1509736.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["01099","000028"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2676629126","title":"国药一致(000028.SZ)前三季度归母净利润9.52亿元 同比下降0.48%","url":"https://stock-news.laohu8.com/highlight/detail?id=2676629126","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2676629126?lang=zh_cn&edition=full","pubTime":"2026-10-20 18:32","pubTimestamp":1792492376,"startTime":"0","endTime":"0","summary":"零售板块实现营业收入152.34亿元,同比增长0.05%;实现净利润0.27亿元,同比增长105.08%。国大药房销售收入逐步回稳,通过持续优化产品结构,战略性调整门店布局,进一步加强费用管控,提升经营质量。报告期内,国大药房净利润实现同比增长。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1509558.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["000028"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2675376769","title":"国药一致(000028)10月14日主力资金净卖出682.15万元","url":"https://stock-news.laohu8.com/highlight/detail?id=2675376769","media":"证券之星","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2675376769?lang=zh_cn&edition=full","pubTime":"2026-10-15 09:05","pubTimestamp":1792026356,"startTime":"0","endTime":"0","summary":"证券之星消息,截至2026年10月14日收盘,国药一致报收于20.55元,上涨2.04%,换手率0.79%,成交量4.17万手,成交额8546.66万元。10月14日的资金流向数据方面,主力资金净流出682.15万元,占总成交额7.98%,游资资金净流出38.15万元,占总成交额0.45%,散户资金净流入720.3万元,占总成交额8.43%。国药一致主营业务:核心业务涵盖以两广区域为主体的医药分销业务和以国大药房为主体的全国性社会药房零售业务,此外还参股医药工业企业。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026101500008003.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0028","BK0082","000028","BK0185","BK0175","BK0188","BK0250","BK0010","BK0196"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2675738990","title":"国药一致(000028)10月12日主力资金净卖出16.93万元","url":"https://stock-news.laohu8.com/highlight/detail?id=2675738990","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2675738990?lang=zh_cn&edition=full","pubTime":"2026-10-13 09:08","pubTimestamp":1791853735,"startTime":"0","endTime":"0","summary":"证券之星消息,截至2026年10月12日收盘,国药一致报收于20.29元,上涨1.65%,换手率0.74%,成交量3.89万手,成交额7850.7万元。融券方面,融券卖出2500.0股,融券偿还6700.0股,融券余量10.68万股,融券余额216.73万元。国药一致主营业务:核心业务涵盖以两广区域为主体的医药分销业务和以国大药房为主体的全国性社会药房零售业务,此外还参股医药工业企业。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026101300008295.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0250","000028","BK0028","BK0175","BK0188","BK0082","BK0196","BK0010","BK0185"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2670019054","title":"股市必读:国药一致(000028)9月24日董秘有最新回复","url":"https://stock-news.laohu8.com/highlight/detail?id=2670019054","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2670019054?lang=zh_cn&edition=full","pubTime":"2026-09-28 03:36","pubTimestamp":1790537773,"startTime":"0","endTime":"0","summary":"截至2026年9月24日收盘,国药一致报收于19.5元,下跌1.12%,换手率0.36%,成交量1.91万手,成交额3747.48万元。董秘最新回复投资者: 回购注销B股,提升内涵价值,增加股东回报。请管理层学学其他公司。当日关注点交易信息汇总:9月24日主力资金净流出81.58万元,占总成交额2.18%。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026092800001711.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["000028","BK0010","BK0082","BK0028","BK0196","BK0175","BK0185","BK0188","BK0250"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2666325075","title":"股市必读:国药一致(000028)9月9日董秘有最新回复","url":"https://stock-news.laohu8.com/highlight/detail?id=2666325075","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2666325075?lang=zh_cn&edition=full","pubTime":"2026-09-10 01:41","pubTimestamp":1788975671,"startTime":"0","endTime":"0","summary":"截至2026年9月9日收盘,国药一致报收于20.3元,下跌0.29%,换手率0.36%,成交量1.9万手,成交额3850.61万元。董秘最新回复投资者: 贵公司您好,请问下国药南沙筹建的国药生命健康产业园目前的进度如何?大概什么时候能投入运行?有无引进先进设施,ai智能技术设备等?该项目尚在施工中,未来会使用现代化技术设备。当日关注点交易信息汇总:9月9日主力资金净流出0.11万元,游资资金净流入98.95万元、占总成交额2.57%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026091000002112.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0250","000028","BK0028","BK0175","BK0188","BK0082","BK0196","BK0010","BK0185"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2666458318","title":"国药一致:该项目尚在施工中,未来会使用现代化技术设备","url":"https://stock-news.laohu8.com/highlight/detail?id=2666458318","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2666458318?lang=zh_cn&edition=full","pubTime":"2026-09-09 15:51","pubTimestamp":1788940294,"startTime":"0","endTime":"0","summary":"证券之星消息,国药一致(000028)09月09日在投资者关系平台上答复投资者关心的问题。投资者提问:贵公司您好,请问下国药南沙筹建的国药生命健康产业园目前的进度如何?大概什么时候能投入运行?有无引进先进设施,ai智能技术设备等?国药一致回复:感谢您的关注。该项目尚在施工中,未来会使用现代化技术设备。本文数据来源于深圳证券交易所互动易,仅供参考不构成投资建议。责任编辑:沈彬","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026090900023067.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0185","BK0010","BK0250","BK0188","BK0082","000028","BK0028","BK0175","BK0196"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2664300888","title":"股市必读:国药一致(000028)8月31日董秘有最新回复","url":"https://stock-news.laohu8.com/highlight/detail?id=2664300888","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2664300888?lang=zh_cn&edition=full","pubTime":"2026-09-01 03:43","pubTimestamp":1788205389,"startTime":"0","endTime":"0","summary":"截至2026年8月31日收盘,国药一致报收于19.91元,下跌0.35%,换手率0.32%,成交量1.69万手,成交额3362.12万元。董秘最新回复投资者: 请问贵公司截至2025年末,公司应收账款规模达到215.38亿元,占总资产比例高达43.87%,2026年一季度进一步攀升至239亿元。利润分配方面,公司分红比例连续两年超30%,2025年度现金分红总额3.42亿元,占2025年度归属于上市公司股东净利润的30.18%。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026090100004146.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0028","BK0082","000028","BK0185","BK0175","BK0188","BK0250","BK0010","BK0196"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2663078094","title":"国药一致:主业优化与提质增效方面,公司持续推进组织结构优化,巩固传统分销基本盘、加快培育新增长引擎,并成立医疗器械中心、医学业务部等,强化专业化运营能力","url":"https://stock-news.laohu8.com/highlight/detail?id=2663078094","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2663078094?lang=zh_cn&edition=full","pubTime":"2026-08-31 15:45","pubTimestamp":1788162311,"startTime":"0","endTime":"0","summary":"主业优化与提质增效方面,公司持续推进组织结构优化,巩固传统分销基本盘、加快培育新增长引擎,并成立医疗器械中心、医学业务部等,强化专业化运营能力。利润分配方面,公司分红比例连续两年超30%,2025年度现金分红总额3.42亿元,占2025年度归属于上市公司股东净利润的30.18%。公司将继续围绕稳经营、提质效等方向增进市场认同,推动公司价值合理反映上市公司质量。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026083100017002.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0250","000028","09996","BK0196","BK0010","BK1100","159883","BK1583","BK0188","BK1574","BK0185","BK0175","BK0028","BK0082"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2663078727","title":"国药一致:通过严格资信管控、专项跟踪清收、持续对账确权、强化法律催收等手段,最大限度降低坏账损失风险","url":"https://stock-news.laohu8.com/highlight/detail?id=2663078727","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2663078727?lang=zh_cn&edition=full","pubTime":"2026-08-31 15:45","pubTimestamp":1788162310,"startTime":"0","endTime":"0","summary":"公司高度重视应收账款风险管控,业务、财务、法务等部门通力合作,高效协同,通过严格资信管控、专项跟踪清收、持续对账确权、强化法律催收等手段,最大限度降低坏账损失风险。强化业务源头管控,通过细化资信管控颗粒度,持续控增量、清存量,降低应收账款风险;升级应收账款风险预警体系,分级分类处置,响应流程更加完善;常态化实施对账确权,确保债权清晰;对高风险客户推进法律催收,保障公司权益。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026083100017000.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0028","BK0082","BK0185","BK0188","BK0250","BK0175","BK0196","000028","BK0010"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2663025516","title":"股市必读:国药一致中报 - 第二季度单季净利润同比下降5.67%","url":"https://stock-news.laohu8.com/highlight/detail?id=2663025516","media":"证券之星","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2663025516?lang=zh_cn&edition=full","pubTime":"2026-08-31 09:19","pubTimestamp":1788139189,"startTime":"0","endTime":"0","summary":"业绩披露要点:2026年中报显示归母净利润6.06亿元,同比下降8.97%。关于对国药集团财务有限公司的风险持续评估报告截至2026年6月30日,国药集团财务有限公司资产规模484.70亿元,资本充足率16.16%,流动性比例58.03%,各项监管指标符合规定;内部控制制度健全,风险管理有效,未发现与财务报表相关的重大风险控制缺陷;公司在其存款余额21,555,649.17元,资金安全性和流动性良好。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026083100003524.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["000028"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2663504385","title":"每周股票复盘:国药一致(000028)2026上半年营收362.66亿","url":"https://stock-news.laohu8.com/highlight/detail?id=2663504385","media":"证券之星","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2663504385?lang=zh_cn&edition=full","pubTime":"2026-08-30 06:36","pubTimestamp":1788042972,"startTime":"0","endTime":"0","summary":"截至2026年8月28日收盘,国药一致报收于19.98元,较上周的19.47元上涨2.62%。本周,国药一致8月27日盘中最高价报20.13元。业绩披露要点国药一致2026年中报显示,上半年度公司主营收入362.66亿元,同比下降1.44%;归母净利润6.06亿元,同比下降8.97%;扣非净利润5.99亿元,同比下降6.84%。国药一致对国药集团财务有限公司开展风险持续评估。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026083000003500.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["000028"],"isVideo":false,"video":null,"gpt_icon":0}],"profile":{"ret":0,"serverTime":1795102954214,"stockEarnings":[{"period":"1week","weight":0.0143},{"period":"1month","weight":0.0386},{"period":"3month","weight":0.0706},{"period":"6month","weight":0.0086},{"period":"1year","weight":-0.0623},{"period":"ytd","weight":-0.0226}],"compareEarnings":[{"period":"1week","weight":-0.0252},{"period":"1month","weight":-0.0384},{"period":"3month","weight":-0.0809},{"period":"6month","weight":-0.1277},{"period":"1year","weight":-0.0893},{"period":"ytd","weight":-0.096}],"compareStock":{"symbol":"000001.SH","name":"上证指数"},"companyName":"国药集团一致药业股份有限公司","boardCode":"AI0051","boardName":"批发业","stockholders":"0人","perCapita":"--","listingDate":"1993-08-09","address":"广东省深圳市福田区园岭街道八卦四路15号一致药业大厦","registeredCapital":"61222万元","survey":" 国药集团一致药业股份有限公司的主营业务是医药分销和医药零售。公司的主要产品是药品、器械耗材、诊断试剂、仪器设备。","listedPrice":3.5},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"isLaohu8Offline":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.54.0","shortVersion":"4.54.0","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"国药一致(000028)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供国药一致(000028)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"国药一致,000028,国药一致股票,国药一致股票老虎,国药一致股票老虎国际,国药一致行情,国药一致股票行情,国药一致股价,国药一致股市,国药一致股票价格,国药一致股票交易,国药一致股票购买,国药一致股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"国药一致(000028)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供国药一致(000028)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}